TMEM256-PLSCR3 readthrough (NMD candidate) (TMEM256-PLSCR3)

TMEM256-PLSCR3 readthrough is a naturally occurring transcript formed by read-through between the genes C17orf61 (TMEM256) and PLSCR3 on chromosome 17. The transcript is subject to nonsense-mediated decay and is not believed to produce a protein product. There is limited research on any possible biological role, and it is not recognized as a functional protein, enzyme, receptor, or drug target. This locus is unlikely to encode a functional protein and is best classified as a non-coding RNA readthrough, sometimes annotated for genomic, transcriptomic, or regulatory studies, but not as a therapeutic target of any class. The entry appears in gene/protein databases for completeness but does not correspond to a traditional druggable target or biologically active protein. Some alternate names (like "PLSCR3") refer to a real gene/protein, but "TMEM256-PLSCR3" specifically refers to the readthrough, not the parent genes themselves. If you are seeking structured target information for drug discovery or therapeutic intervention, TMEM256-PLSCR3 should not be considered a conventional target due to its classification and lack of evidence for encoding functional protein.

Other names

C17ORF61-PLSCR3PLSCR3